VLO News 49.85 07/30/2014 05:49:50 Valero Energy Corp (VLO)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Valero Energy Corp (VLO) 49.85 $VLO

Valero Energy Set to Possibly Pullback After Yesterday's Rally of 1.66%
Comtex SmarTrend(R) - Tue Jul 29, 3:54PM CDT
Valero Energy (NYSE:VLO) traded in a range yesterday that spanned from a low of $49.42 to a high of $50.40. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $49.44 on volume of 9.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

After Yesterday's Rally of 1.66% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Jul 29, 3:54PM CDT
Valero Energy (NYSE:VLO) traded in a range yesterday that spanned from a low of $49.42 to a high of $50.40. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $49.44 on volume of 9.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Valero Energy (VLO) Declares 27.5c Quarterly Dividend
at The Street - Tue Jul 29, 10:51AM CDT
Valero Energy (VLO) declares a quarterly dividend of 27.5 cents a share, a 10% increase from the company's previous dividend of 25 cents a share.

Four Undervalued Large Cap Stocks With Low Comparative Prices
at The Street - Tue Jul 29, 9:16AM CDT
By Robbie Citrino for Kapitall. The price-to-earnings ratio (P/E), the most quoted comparative valuation metric on Wall Street, assesses the relative price [...]

Watch for Shares of Valero Energy (VLO) to Approach Resistance at $50.01
Comtex SmarTrend(R) - Tue Jul 29, 9:00AM CDT
Valero Energy (NYSE:VLO) has opened bullishly above the pivot of $48.95 today and has reached the first level of resistance at $49.53. Analysts will be watching for a cross of the next upside pivot targets of $50.01 and $51.07.

Will Valero Energy (VLO) Miss on Q2 Earnings this Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 28, 12:30PM CDT
Valero Energy Corporation (VLO) is expected to report second-quarter 2014 earnings on Jul 30, before the opening bell.

Valero Energy Rises 1.07% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Jul 25, 4:07PM CDT
Valero Energy (NYSE:VLO) traded in a range yesterday that spanned from a low of $48.45 to a high of $49.24. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $49.10 on volume of 5.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Next Resistance Level for Valero Energy (VLO) is $49.55
Comtex SmarTrend(R) - Fri Jul 25, 12:27PM CDT
Shares of Valero Energy (NYSE:VLO) opened today above their pivot of $48.66 and have already reached the first level of resistance at $49.12. Analysts will be watching for a cross of the next upside pivot targets of $49.55 and $50.44.

Are These 3 Refiners Doomed?
Adam Galas, The Motley Fool - Motley Fool - Thu Jul 24, 2:16PM CDT
Refining is a tough business. Environmental regulations and high capital costs have resulted in no new refineries being built in the US since 1976. It's also a highly cyclical business, with margins often tied to not only the price of oil, but the...

Northern Tier Energy Might Not Be the Only Refiner Hurting This Quarter
Tyler Crowe, The Motley Fool - Motley Fool - Thu Jul 24, 12:30PM CDT
Life has been pretty good for refiners for the past five years, especially those with refineries in the middle of the country that have been able to take advantage of the shale boom such as HollyFrontier , Northern Tier Energy , and CVR Refining...

Cramer/Dicker: Refiners Are a Huge Stock No-No Right Now
at The Street - Thu Jul 24, 11:12AM CDT
Dan Dicker talks with Jim Cramer about the continuing shrinking in the price difference between West Texas Intermediate crude and the Brent crude global benchmark.

Are Hewlett-Packard and Valero Energy Bargains Right Now?
Selena Maranjian, The Motley Fool - Motley Fool - Wed Jul 23, 9:59AM CDT
Credit : Stuart , Flickr. Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some large-cap value stocks to your portfolio but don't have the time or expertise to hand-pick a few,...

Oil & Gas Stock Roundup: Shell Strikes in GoM, Chevron Starts New Oil Plant - Analyst Blog
Nilanjan Choudhury - Zacks Investment Research - Tue Jul 22, 1:03PM CDT
Apart from the usual releases in this week ??? the U.S. government data on oil and natural gas ??? market participants will be closely tracking releases on housing, inflation, durable orders and jobless claims, apart from a host of earnings reports.

Look for Shares of Valero Energy to Potentially Rebound after Yesterday's 2.03% Sell Off
Comtex SmarTrend(R) - Mon Jul 21, 3:52PM CDT
Valero Energy (NYSE:VLO) traded in a range yesterday that spanned from a low of $47.77 to a high of $48.78. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $48.75 on volume of 7.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Decline of 2.03%, Valero Energy Offers Investors Better Value
Comtex SmarTrend(R) - Mon Jul 21, 3:51PM CDT
Valero Energy (NYSE:VLO) traded in a range yesterday that spanned from a low of $47.77 to a high of $48.78. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $48.75 on volume of 7.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Valero Energy Continues to Lose Ground, but Will It Last?
Lior Cohen, The Motley Fool - Motley Fool - Mon Jul 21, 11:53AM CDT
In anticipation of the release of Valero Energy 's second-quarter report, the company released an interim update for the past quarter. This report puts its income from operating activities at a range of $1.10-$1.25 per share, or an average of...

Making the Most of the Overreaction in Refiners
Marshall Hargrave, The Motley Fool - Motley Fool - Sun Jul 20, 2:19PM CDT
It has been a tough month for oil and gas refiners. Many of the leading companies in the sector have seen large sell-offs. The news that the Commerce Department opened up the "floodgates" for U.S. oil exports drove this sell-off. However, in truth,...

NY pension fund seeks political spending reports
By MICHAEL VIRTANEN - AP - Fri Jul 18, 7:05PM CDT
ALBANY, N.Y. (AP) — New York's $176.2 billion pension fund for public workers this year has proposed 29 corporations more thoroughly disclose their political spending.

Executive Appointment, Interim Update on Quarterly Results, and Conference Call Schedule - Analyst Notes on Whiting, Valero Energy, Occidental Petroleum, EP Energy and Swift Energy
PR Newswire - Fri Jul 18, 7:50AM CDT
Today, Analysts Review released its analysts' notes regarding Whiting Petroleum Corp. (NYSE: WLL), Valero Energy Corporation (NYSE: VLO), Occidental Petroleum Corporation (NYSE: OXY), EP Energy Corporation (NYSE: EPE) and Swift Energy Co. (NYSE: SFY). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4869-100free.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Market Shake-Up: GDP Climbs, Stocks Dive

Updated Category News Views 114

See the Forest, Amid the Trees Alright, folks, the market's mood swings faster than a teenager's. Despite a third-quarter GDP growth punching 3.4% up from 2.2% last quarter, stocks took a nosedive Thursday morning. The S&P 500 tanked 3.39%, Nasdaq sank 5.08%, and even the stodgy Dow dropped 2.37%. Yet, don't let the red on the screen fool you—year-to-date gains are...

Continue Reading
Lynk's Zemprocitinib Set for RA Markets: NDA Accepted

Updated Category News Views 101

A Step Closer for Zemprocitinib: Here's the Lowdown Surprise in the pharma skies as Lynk Pharmaceuticals takes a major leap with its new gem, zemprocitinib, entering the regulatory review phase. The center buzzed on November 4 when China's NMPA gave the coveted nod to this New Drug Application (NDA). Seems the race for rheumatoid arthritis (RA) treatments just got a...

Continue Reading
Norwegian Cruise Line's Black Friday Big Splash

Updated Category News Views 126

Jump Aboard NCL's Black Friday Bargain Ship Grab your life jackets, folks! Norwegian Cruise Line (NCL) is sailing with an irresistible Black Friday offer: 50% off all cruises, complete with their much-lauded Free at Sea package. Yeah, if you've been fence-sitting about taking the plunge into the cruise lifestyle, now might just be the time to buckle up your life vests. A...

Continue Reading
Research Solutions Set to Reveal Q1 FY27 Results

Updated Category News Views 68

Understanding the Stakes Ahead of RSSS's Earnings Call Aw, the sweet suspense of earnings season. Research Solutions, Inc. (NASDAQ: RSSS) has circled November 12, 2026, as the date to let investors in on its numbers for the first quarter of fiscal year 2027. A date that's gotta have the folks over at RSSS feeling like it’s judgment day. You know how it goes—market...

Continue Reading
Intensity Therapeutics: Q3 Results Show Steady Progress

Updated Category News Views 104

Patient Enrollment Back on Track Today feels like we're talking about a company that's finally shaking off the cobwebs—Intensity Therapeutics is back in action with their cancer trials. After hitting the brakes back in March 2025 thanks to a cash crunch, it looks like Intensity is revving up once more, thanks to some better financial footing. They've got their Phase 3...

Continue Reading
Hexagon Composites Q3 2026: Demand Boosts Revenues

Updated Category News Views 99

I bet Hexagon's investors are waking up with a grin today. These guys made a cool NOK 929 million in revenue for Q3 2026, leaping up from NOK 538 million last year. Now, ain't that a sight for sore eyes? They posted a NOK 108 million EBITDA while grumbling was swapped with a 12% margin—no longer in the red. Breaking Down Hexagon's Climb Hexagon Composites (OSE: HEX.OL)...

Continue Reading
Vermiculus Taps New CISO Amid Index Engine Launch

Updated Category News Views 46

Vermiculus Ups Its Security Game You ever wonder why a company decides to beef up security? Well, Vermiculus ain't leaving anything to chance as they roll out new tech. They've named Alexander Kilian the Chief Information Security Officer. Yep, Kilian's stepping into the ring, and no one’s treating this like a sidebar gig. This market tech outfit isn't just polishing...

Continue Reading
Koozee Boosts Apparel Design with AI Workflows

Updated Category News Views 108

Revolutionizing Apparel Design with AI If you've ever wondered how tech can make an impact on the fashion world, Koozee's latest update provides an eye-opening look. This isn't about following trends—it's about setting them, and Koozee’s making a bold move with its newest platform enhancements. Introducing Freeform Canvas Koozee has launched the Freeform Canvas, a...

Continue Reading
Real Estate Sage: Tad Barber's Tips on Selling Your Home

Updated Category News Views 173

Kicking Off the 2027 Home Selling Game Plan Let me tell you, the real estate world isn't for the faint-hearted. It’s a realm where a solid game plan makes a world of difference, especially when you're thinking about selling your home in 2027. In Aiken, South Carolina, it seems the local know-it-all Tad Barber has teamed up with HelloNation to throw down some insight on...

Continue Reading
Sharon Bowen Honored; e.l.f. Beauty Hits 31 Quarters

Updated Category News Views 185

Markets Stir as NYSE Chair Earns Lifetime Award While the financial world often gets lost in numbers, sometimes it's the people who stand out. NYSE Chair Sharon Bowen is taking the spotlight with her lifetime achievement award, underscoring her game-changing influence in governance. This is more than just a pat on the back; it's a nod to the force she’s been in steering...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Future of Web3: Insights from KuCoin's Panel

Updated Category News Views 148

Insights into Web3 Development At a recent gathering during Hackseason, KuCoin's Managing Director, Alicia Kao, moderated a significant panel that explored the direction of Web3 technologies. The panel featured distinguished voices from the blockchain and Web3 sectors, highlighting their expertise and collaborative spirit. The session, aptly titled "Where is Web3 Headed...

Continue Reading
Crypto Losses Are Reshaping Investor Behavior, and the Market Itself

Updated Category Crypto Views 169

About a third of cryptocurrency investors have reportedly cut their daily spending due to digital asset losses. Research demonstrates that people who lose money in crypto experience more than temporary discomfort, highlighting a concrete link between crypto markets and the real world. The market decline, which has persisted for some time, is the main reason behind this...

Continue Reading
Crest Holdings Group's Vision and Leadership by Antwain Baker

Updated Category News Views 182

Leadership Insights of Antwain Baker at Crest Holdings Group LLC Crest Holdings Group LLC recently highlighted its leadership journey and vision under the guidance of Founder and CEO Antwain Baker. This Atlanta-based consulting and holding firm is dedicated to enhancing business operations across various sectors. The Approach of Antwain Baker With a rich background in...

Continue Reading
Celebrating Half a Century of Excellence at Katsky Korins Firm

Updated Category News Views 204

Katsky Korins Marks 50 Years of Legal Excellence "Humanity is our X Factor" Katsky Korins, a distinguished law firm based in New York City, proudly announces its milestone of celebrating 50 years of dedicated service in the legal profession. Established in 1975, it stands as one of the longest-serving general practice law firms in the bustling city, earning a remarkable...

Continue Reading
Seres Therapeutics Enhances SER-155 Study Protocol Amid Cost Cuts

Updated Category News Views 232

Seres Therapeutics Makes Significant Progress with SER-155 Recently, Seres Therapeutics has received valuable feedback from regulatory authorities, which is paving the way for the completion of its important SER-155 Phase 2 study protocol. This study focuses on preventing bloodstream infections in adults who are undergoing allogeneic hematopoietic stem cell transplant for...

Continue Reading